keyword
https://read.qxmd.com/read/38688315/medical-therapy-of-endogenous-cushing-s-syndrome-with-steroidogenesis-inhibitors-treatment-rationale-available-drugs-and-therapeutic-effects
#1
JOURNAL ARTICLE
Mario Detomas, Timo Deutschbein, Barbara Altieri
Endogenous Cushing's syndrome (CS) is a rare disease characterized by a glucocorticoid excess. If inadequately treated, the latter can lead to increased morbidity and mortality. Surgical removal of the underlying tumor is the first line treatment but is sometimes not feasible or even contraindicated. Additionally, in cases with severe CS, rapid control of hypercortisolism may be required. In these scenarios steroidogenesis inhibitors represent a therapeutic alternative to surgery. Over the last years, the knowledge on the broad therapeutic effects of steroidogenesis inhibitors and the number of available drugs have increased...
April 30, 2024: Experimental and Clinical Endocrinology & Diabetes
https://read.qxmd.com/read/38686896/an-overlooked-disease-minimal-autonomous-cortisol-secretion-macs-a-narrative-review
#2
JOURNAL ARTICLE
Stephanie Farah, Leah Nasr, Jocelyne Eid Fares
BACKGROUND: A far more common disease than Cushing's syndrome is subclinical hypercortisolism or mild autonomous cortisol secretion (MACS), with an overall prevalence of 0.2-2%. OBJECTIVE: This review aims to shed light on the prevalence, screening and diagnostic criteria, comorbidities, and management of Mild Autonomous Cortisol Secretion (MACS). METHODS: Studies eligible targeted MACS regarding prevalence, screening, comorbidities, management, and clinical outcome...
February 16, 2024: Endocrine, Metabolic & Immune Disorders Drug Targets
https://read.qxmd.com/read/38663485/long-term-glucocorticoid-infusion-impairs-epididymal-adipocyte-metabolism-and-maturation-and-affects-mir-150-5p-actions
#3
JOURNAL ARTICLE
Rafael Barrera Salgueiro, Anaysa Paola Bolin, Sandra Andreotti, Ayumi Cristina Medeiros Komino, Érica de Sousa, Flaviane de Fatima Silva, André Ricardo Gomes de Proença, Rogério Antonio Laurato Sertié, Alice Cristina Rodrigues, Fabio Bessa Lima
The most common form of hypercortisolism is iatrogenic Cushing's syndrome. Lipodystrophy and metabolic disorders can result from the use of exogenous glucocorticoids (GC). Adipocytes play an important role in the production of circulating exosomal microRNAs, and knockdown of Dicer promotes lipodystrophy. The aim of this study is to investigate the effect of GCs on epididymal fat and to assess their influence on circulating microRNAs associated with fat turnover. The data indicate that despite the reduction in adipocyte volume due to increased lipolysis and apoptosis, there is no difference in tissue mass, suggesting that epididymal fat pad, related to animal size, is not affected by GC treatment...
April 23, 2024: Molecular and Cellular Endocrinology
https://read.qxmd.com/read/38660483/a-large-benign-adrenocortical-adenoma-cosecreting-testosterone-and-cortisol
#4
Martha Dillon, Sara Shteyman, Samaneh Rabiehashemi, Parvathy Madhavan, Pooja Luthra
Most adrenal incidentalomas are benign neoplasms of the adrenal cortex. While the majority are nonfunctional, many secrete cortisol. Androgen- or estrogen-secreting adenomas are rare. A 44-year-old female, with history of hypertension and prediabetes, presented with worsening acne, hirsutism, secondary amenorrhea for 2 years, and a 40-pound weight gain. Laboratory evaluation showed high 24-hour urine free cortisol, suppressed adrenocorticotropic hormone (ACTH) level, indicative of ACTH independent Cushing syndrome, and elevated testosterone and androstenedione...
May 2024: JCEM Case Rep
https://read.qxmd.com/read/38650766/cushing-s-syndrome-and-a-dead-fetus-in-pregnancy-a-clinical-case-and-behavior-report
#5
Zhivko Zhekov, Svetlana Y Radeva, Yanko G Yankov
Cushing's syndrome is a rare disease that has a different primary etiology, most often due to chronic hypercortisolism. In addition to the defined causes, in contrast to the general population, the observed etiology in pregnant women is a benign adrenocortical adenoma, less often bilateral hyperplasia of the adrenal glands of hypothalamic-pituitary origin or Cushing's disease, and malignant adrenal root adenoma. In this study, we present the case of a 41-year-old pregnant woman experiencing her first pregnancy...
March 2024: Curēus
https://read.qxmd.com/read/38647982/no-requirement-of-perioperative-glucocorticoid-replacement-in-patients-with-endogenous-cushing-s-syndrome-a-pilot-study
#6
JOURNAL ARTICLE
Christian Trummer, Marlene Pandis, Verena Theiler-Schwetz, Lisa Schmitt, Barbara Obermayer-Pietsch, Verena Gellner, Andrea Simon, Stefan Pilz
PURPOSE: Surgical therapy represents the first-line treatment for endogenous Cushing's syndrome (CS). While postoperative glucocorticoid replacement is mandatory after surgical remission, the role of perioperative glucocorticoid therapy is unclear. METHODS: We recruited patients with central or adrenal CS in whom curative surgery was planned and patients who underwent pituitary surgery for other reasons than CS as a control group. Patients did not receive any perioperative glucocorticoids until the morning of the first postoperative day...
April 22, 2024: Endocrine
https://read.qxmd.com/read/38643895/trabecular-bone-score-tbs-in-cushing-s-disease-tbs-gain-after-hypercortisolism-normalization
#7
JOURNAL ARTICLE
Elina Tan, Laurence Guignat, Azeddine Dellal, Renaud Winzenrieth, Catherine Cormier, Eugénie Koumakis
CONTEXT: Hypercortisolism frequently induces trabecular bone loss, more pronounced at the lumbar spine, resulting in osteoporosis, and thus an increase in fracture risk. Several studies have shown bone mass recovery in patients with Cushing's disease (CD) after treatment. OBJECTIVE: To examine treatment effects on TBS (trabecular bone score) in addition to aBMD (areal bone mineral density) in a cohort of patients with CD. DESIGN AND SETTING: Single-center retrospective longitudinal study in patients diagnosed with CD and successfully treated following surgery and/or medical treatment...
April 19, 2024: Bone
https://read.qxmd.com/read/38626717/adrenalectomy-outcome-variations-across-different-functional-adrenal-tumors
#8
JOURNAL ARTICLE
Terry P Gao, Rebecca L Green, Lindsay E Kuo
INTRODUCTION: Adrenalectomy generally has favorable outcomes. It is unknown if patients with functional adrenal tumors experience different clinical outcomes than those with benign adrenal tumors, due to the presence of comorbid conditions secondary to the functional tumor. We investigated outcomes following open and laparoscopic adrenalectomy for benign nonfunctional (BNF) versus functional adrenal masses. METHODS: Patients undergoing adrenalectomy were identified in the 2015-2020 National Surgical Quality Improvement Program database, then categorized as BNF, hyperaldosteronism, hypercortisolism, and pheochromocytoma...
April 15, 2024: Journal of Surgical Research
https://read.qxmd.com/read/38622799/evaluation-of-muscle-mass-and-intramuscular-fatty-infiltration-in-dogs-with-hypercortisolism-and-their-association-with-prognosis
#9
JOURNAL ARTICLE
Kei Yoshida, Yui Kobatake, Satoshi Takashima, Naohito Nishii
BACKGROUND: Muscle atrophy and intramuscular fatty infiltration, as well as their association with prognosis, have not been quantified in dogs with spontaneous hypercortisolism (HC). OBJECTIVE: To quantitatively evaluate muscle atrophy and IM fatty infiltration in dogs with HC and determine their prognostic impact. ANIMALS: Fifty-three dogs with HC and 66 control dogs without HC. METHODS: Retrospective cohort study. Medical records and computed tomography images obtained between 2014 and 2021 were evaluated...
April 15, 2024: Journal of Veterinary Internal Medicine
https://read.qxmd.com/read/38616817/response-to-osilodrostat-therapy-in-adrenal-cushing-s-syndrome
#10
Magdalena Stasiak, Przemysław Witek, Emilia Adamska-Fita, Andrzej Lewiński
Cushing's disease (CD) is the most common cause of endogenous hypercortisolism. Osilodrostat was demonstrated to be efficient in treating CD, and the mean average dose required for CD control was <11 mg/day. Potential differences in osilodrostat treatment between cortisol-producing adenoma (CPA) and CD have not been reported. The aim of this study was to present two patients with CPA in whom significant differences in the response to therapy compared to CD were found. We demonstrated a case of inverse response of cortisol levels with adrenal tumor progression during the initial dose escalation (Case 1)...
2024: Drug, Healthcare and Patient Safety
https://read.qxmd.com/read/38612585/oxidative-stress-induced-by-cortisol-in-human-platelets
#11
JOURNAL ARTICLE
Maria Grazia Signorello, Silvia Ravera, Giuliana Leoncini
Hypercortisolism is known to affect platelet function. However, few studies have approached the effect of exogenous cortisol on human platelets, and the results obtained are conflicting and unconvincing. In this study, the effect of exogenous cortisol on several parameters indicative of oxidative status in human platelets has been analysed. We have found that cortisol stimulates ROS production, superoxide anion formation, and lipid peroxidation, with these parameters being in strict correlation. In addition, cortisol decreases GSH and membrane SH-group content, evidencing that the hormone potentiates oxidative stress, depleting platelet antioxidant defence...
March 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38606215/hypokalemic-periodic-paralysis-a-rare-case-of-a-descending-flaccid-paralysis
#12
Inder Preet Singh Bhatia, Jayaraj Hasvi, Pandaramparambil Saidu Nazneen, Amit Rajan
Hypokalemic periodic paralysis (HPP) is an uncommon condition resulting from channelopathy, impacting skeletal muscles. It is distinguished by episodes of sudden and temporary muscle weakness alongside low potassium levels. The normalization of potassium resolves the associated paralysis. Most of these cases are hereditary. Few cases are acquired and are associated with an etiology related to endocrine disorders (e.g., thyrotoxicosis, hyperaldosteronism, and hypercortisolism). It is characterized by acute flaccid paralysis, usually of the ascending type, affecting the proximal region more than the distal region...
March 2024: Curēus
https://read.qxmd.com/read/38601682/analysis-of-brain-structural-covariance-network-in-cushing-disease
#13
JOURNAL ARTICLE
Can-Xin Xu, Linghan Kong, Hong Jiang, Yue Jiang, Yu-Hao Sun, Liu-Guan Bian, Yuan Feng, Qing-Fang Sun
BACKGROUND: Cushing disease (CD) is a rare clinical neuroendocrine disease. CD is characterized by abnormal hypercortisolism induced by a pituitary adenoma with the secretion of adrenocorticotropic hormone. Individuals with CD usually exhibit atrophy of gray matter volume. However, little is known about the alterations in topographical organization of individuals with CD. This study aimed to investigate the structural covariance networks of individuals with CD based on the gray matter volume using graph theory analysis...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38601065/from-knee-pain-consultation-to-pituitary-surgery-the-challenge-of-cushing-disease-diagnosis
#14
Maria Alejandra Gómez-Gutiérrez, Juan Miguel Huertas-Cañas, Andrés Bedoya-Ossa
Cushing syndrome (CS) is a rare endocrinological disorder resulting from chronic exposure to excessive cortisol. The term Cushing disease is used specifically when this is caused by excessive secretion of adrenocorticotropic hormone (ACTH) by a pituitary tumor, usually an adenoma. This disease is associated with a poor prognosis, and if left untreated, it has an estimated 5-year survival rate of 50%. We present the case of a 66-year-old female patient who received a referral to endocrinology for an evaluation of obesity due to right knee arthropathy...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38574761/subtyping-of-cushing-s-syndrome-a-step-ahead
#15
JOURNAL ARTICLE
Irene Tizianel, Mattia Barbot, Filippo Ceccato
Cushing's Syndrome (CS) is a rare disease due to chronic endogenous cortisol secretion. In the last years, new acquisitions enlarged the spectrum of differential diagnosis, historically divided into ACTH-dependent and ACTH-independent forms. Moreover, the increased awareness of the detrimental cortisol effects on cardiometabolic health and the risk of cardiovascular events lead to increased diagnosis of mild forms, especially in the context of adrenal incidentalomas. We provide and up-to-date narrative review of the most recent literature regarding the challenges of CS diagnosis...
April 4, 2024: Experimental and Clinical Endocrinology & Diabetes
https://read.qxmd.com/read/38571672/unveiling-the-hidden-impact-subclinical-hypercortisolism-and-its-subtle-influence-on-bone-health
#16
REVIEW
Yuan Lou, Luping Ren, Huan Chen, Tian Zhang, Qi Pan
In recent years, advancements in imaging technologies have led to an increased detection rate of adrenal incidentalomas (AI), with age demonstrating a significant correlation with their incidence. Among the various forms of functional adrenal incidentalomas, subclinical hypercortisolism (SH) stands out as a predominant subtype. Despite the absence of typical symptoms associated with Cushing's syndrome, both domestic and international research consistently establishes a robust link between SH and diverse metabolic irregularities, including hypertension, lipid metabolism disorders, glucose metabolism abnormalities, and disruptions in bone metabolism...
February 2024: Aging medicine
https://read.qxmd.com/read/38561211/glucocorticoid-induced-adrenal-insufficiency-and-glucocorticoid-withdrawal-syndrome-two-sides-of-the-same-coin
#17
REVIEW
Noura Nachawi, Dingfeng Li, M Cecilia Lansang
Diseases of the adrenal glands can lead to primary adrenal insufficiency, and suppression of the hypothalamic-pituitary-adrenal axis can cause secondary adrenal insufficiency (adrenal suppression). The most common cause of adrenal suppression is exogenous steroids, a condition recently termed glucocorticoid-induced adrenal insufficiency (GIAI). Similarly, weaning from high doses of glucocorticoids or giving insufficient glucocorticoid replacement after curative surgery for endogenous hypercortisolism (Cushing syndrome) can lead to glucocorticoid withdrawal syndrome, which overlaps with GIAI...
April 1, 2024: Cleveland Clinic Journal of Medicine
https://read.qxmd.com/read/38557479/the-risk-of-covid-19-in-cushing-s-disease-is-independently-related-to-disease-activity-hypercortisolism-and-obesity
#18
JOURNAL ARTICLE
Bruna M G Mascarenhas-Nakano, Silvia R Correa-Silva, Silvia M R Fracacio, Paola W Brock, Rossella F Dias, Eduarda S S Binda, Pedro F Santos-Neto, Luiz H C Portari, Adriana Sanudo, Julio Abucham
OBJECTIVE: To evaluate the cumulative incidence, risk factors, and outcomes of COVID-19 in patients with Cushing's disease (CD). SUBJECTS AND METHODS: In all, 60 patients with CD following up in our outpatient clinic answered via phone interview a questionnaire about the occurrence of COVID-19 infection documented by RT-PCR (including the diagnosis date and clinical outcome) and vaccination status. Clinical and biochemical data on disease activity (hypercortisolism) and comorbidities (obesity, diabetes mellitus, and hypertension) were obtained from the patients' electronic medical records...
March 27, 2024: Archives of Endocrinology and Metabolism
https://read.qxmd.com/read/38541884/obesity-related-hemodynamic-alterations-in-patients-with-cushing-s-disease
#19
JOURNAL ARTICLE
Agnieszka Jurek, Paweł Krzesiński, Beata Uziębło-Życzkowska, Przemysław Witek, Grzegorz Zieliński, Robert Wierzbowski, Anna Kazimierczak, Małgorzata Banak, Grzegorz Gielerak
Background : Cushing's disease (CD) is associated with a specific form of metabolic syndrome that includes visceral obesity, which may affect cardiovascular hemodynamics by stimulating hypercortisolism-related metabolic activity. The purpose of this study was to evaluate the relationship between obesity and the hemodynamic profile of patients with CD. Methods : This prospective clinical study involved a hemodynamic status assessment of 54 patients newly diagnosed with CD with no significant comorbidities (mean age of 41 years)...
March 14, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38532898/cushing-s-syndrome-during-pregnancy-two-case-reports
#20
Sumita Cholekho, Yuke Liu, Huiwen Tan
BACKGROUND: Cushing's syndrome (CS) during pregnancy is a rare endocrine disorder characterized by hypercortisolism, which is significantly associated with maternal-fetal complications. Despite its rarity, CS during pregnancy may be related to a high risk of complications for both the mother and fetus.The aim of the present case study is to update the diagnostic approach to CS during pregnancy and the therapeutic strategies for this medical condition to minimize maternal-fetal complications...
2024: Frontiers in Endocrinology
keyword
keyword
13754
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.